What is Nvax new price target?
Stock Price Target NVAXHigh$250.00Median$189.50Low$150.00Average$194.67Current Price$53.69
Who owns Nvax?
The Vanguard Group, Inc.Top 10 Owners of Novavax IncStockholderStakeShares ownedThe Vanguard Group, Inc.8.90%6,787,173BlackRock Fund Advisors4.65%3,549,765RA Capital Management LP2.75%2,097,794SSgA Funds Management, Inc.2.49%1,899,2206 more rows
How many shares of NVAX are there?
Share StatisticsAvg Vol (3 month) 34.74MShares Outstanding 576.28MImplied Shares Outstanding 6N/AFloat 875.89M% Held by Insiders 10.55%7 more rows
Is Novavax a publicly traded company?
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases....Novavax.TypePublic companyKey peopleStanley Erck (CEO) Gregory Glenn (R&D)ProductsVaccinesRevenueUS$475.2 million (2020)Number of employees791 (February 24, 2021)8 more rows
What mutual funds hold Novavax?
Largest shareholders include Vanguard Group Inc, BlackRock Inc., Susquehanna International Group, Llp, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, Ra Capital Management, L.p., Susquehanna International Group, Llp, NAESX - Vanguard Small-Cap Index Fund Investor Shares, State Street Corp, Citadel ...
Does Vanguard own Novavax?
2022-02-10 - Vanguard Group Inc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,897,007 shares of Novavax, Inc. (US:NVAX). This represents 9.12 percent ownership of the company.
Has Novavax applied for FDA approval?
It's finally here: After a series of delays in the lead-up to Novavax's COVID-19 vaccine filing with the FDA, the biotech has completed its emergency use authorization request. Novavax on Monday said it filed NVX-CoV2373 for use in people 18 and older.
What type of vaccine is Novavax?
Novavax is a protein-based vaccine. This type of vaccine contains part of the coronavirus spike protein. Your immune system cells recognise the spike protein as a threat and begin building an immune response against it. The Novavax vaccine also has an ingredient called the Matrix-M adjuvant.Jan 20, 2022
Who is making Covaxin?
COVAXIN®, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
Who makes the Moderna vaccine?
Manufacturer: ModernaTX, Inc. Number of Shots: 2 doses in the primary series, given 4–8 weeks apart. People ages 18 years and older who are moderately or severely immunocompromised should get a third dose at least 4 weeks after their second dose.
Where is Pfizer vaccine made?
Where is the Pfizer-BioNTech COVID-19 vaccine made? As of January 2022, the Pfizer-BioNTech COVID-19 vaccine is manufactured between 11 sites across five countries, including the U.S., Germany, Belgium, Ireland, and Croatia, and engages more than 20 suppliers.